Effects of bosentan on nondigital ulcers in patients with systemic sclerosis.

Taniguchi, T; Asano, Y; Hatano, M; Tamaki, Z; Tomita, M; Kawashima, T; Miyazaki, M; Sumida, H; Akamata, K; Takahashi, T; Ichimura, Y; Toyama, T; Sugita, M; Noda, S; Yao, A; Kinugawa, K; Sato, S

Taniguchi, T; Asano, Y; Hatano, M; Tamaki, Z; Tomita, M; Kawashima, T; Miyazaki, M; Sumida, H; Akamata, K; Takahashi, T; Ichimura, Y; Toyama, T; Sugita, M; Noda, S; Yao, A; Kinugawa, K; Sato, S.

Affiliation

Taniguchi T; Departments of Dermatology and Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Br J Dermatol ; 166(2): 417-21, 2012 Feb.

Article in En | MEDLINE | ID: mdl-21848685

Subject(s)

Antihypertensive Agents/therapeutic use; Dermatologic Agents/therapeutic use; Foot Ulcer/drug therapy; Scleroderma, Systemic/complications; Sulfonamides/therapeutic use; Adult; Aged; Aged, 80 and over; Bosentan; Female; Humans; Hypertension, Pulmonary/drug therapy; Middle Aged; Off-Label Use; Treatment Outcome; Wound Healing/drug effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Sulfonamides / Foot Ulcer / Dermatologic Agents / Antihypertensive Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Dermatol Year: 2012 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google